Aston Sci. Inc.
PrivateLast Round
Series D
Aug 20, 2026
Est. Valuation
$40.2M
Total Funding Raised
$81.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aston Sci. Inc. operates in Healthcare & Life Sciences and is based in Hanam-si. Its latest recorded funding round was a Series D round in August 2026.
Aston Sci. Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in oncology, immunology, and geriatrics, including therapeutic cancer vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aston Sci. Inc. Comparables
Compare Aston Sci. Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anixa Biosciences, Inc. | 80% | |
| Gritstone bio | 78% | |
| IO Biotech | 78% |
For institutional investors. Book with your work email.
Aston Sci. Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 20, 2026 | ||||
| Series D | Apr 1, 2026 | ||||
| Series C | Dec 1, 2021 | ||||
| Series B | Nov 1, 2020 | ||||
| Series A | Nov 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aston Sci. Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ID Ventures | Series D |
| CKD Venture Capital | Series D |
| Shinhan Venture Investment | Series C |
| Korea Investment Partners | Series D |
| KB Investment | Series C |
| SBI Investment Korea | Series D |
| Timefolio Asset Management | Series A, Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
$28M round with participation from CKD Venture Capital and Kolon Investment.
- Apr 1, 2026
$13M round completed.
For institutional investors. Book with your work email.
Aston Sci. Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aston Sci. Inc.'s valuation, stock price, and market status.
Is Aston Sci. Inc. a public or private company?
Aston Sci. Inc. is a private company.
What is the current stock price of Aston Sci. Inc.?
Aston Sci. Inc. is a private company, so its shares have no public market price. Caplight tracks Aston Sci. Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aston Sci. Inc. worth (valuation)?
Aston Sci. Inc.'s valuation is estimated at $40.2M based on funding round data.
Can I buy Aston Sci. Inc. stock?
Aston Sci. Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aston Sci. Inc.'s last funding round?
Aston Sci. Inc.'s most recent funding round was Series D on August 20, 2026.
Who are the main investors in Aston Sci. Inc.?
Key investors in Aston Sci. Inc. include ID Ventures, CKD Venture Capital, Shinhan Venture Investment, Korea Investment Partners, KB Investment.
Will Aston Sci. Inc. IPO soon?
No public IPO plans have been announced for Aston Sci. Inc..
How can I track Aston Sci. Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Aston Sci. Inc.'s shares on secondary markets.